Immunmonitoring von Patienten mit schubförmig-remittierender Multipler Sklerose unter Therapie mit Interferon-beta 1b (Betaferon®)
Date
2003
We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.